Search Results - "Gunsar, F."

Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients with Autoimmune Hepatitis by Efe, Cumali, Hagström, Hannes, Ytting, Henriette, Bhanji, Rahima A, Müller, Niklas F, Wang, Qixia, Purnak, Tugrul, Muratori, Luigi, Werner, Mårten, Marschall, Hanns-Ulrich, Muratori, Paolo, Gunşar, Fulya, Klintman, Daniel, Parés, Albert, Heurgué–Berlot, Alexandra, Schiano, Thomas D, Cengiz, Mustafa, May-Sien Tana, Michele, Ma, Xiong, Montano-Loza, Aldo J, Berg, Thomas, Verma, Sumita, Larsen, Fin Stolze, Ozaslan, Ersan, Heneghan, Michael A, Yoshida, Eric M, Wahlin, Staffan

“…Abstract Background Predniso(lo)ne, alone or in combination with azathioprine, is the standard of care (SOC) therapy for autoimmune hepatitis (AIH). However,…”
Get full text

Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting by Idilman, R., Gunsar, F., Koruk, M., Keskin, O., Meral, C. E., Gulsen, M., Elhan, A. H., Akarca, U. S., Yurdaydin, C.

“…Summary The aim of this study was to determine the long‐term efficacy of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) on the natural course of…”
Get full text

Nutritional status and prognosis in cirrhotic patients by GUNSAR, F., RAIMONDO, M. L., JONES, S., TERRENI, N., WONG, C., PATCH, D., SABIN, C., BURROUGHS, A. K.

“…SUMMARY Background and Aim  The potential prognostic value for survival of nutritional status in cirrhotics after adjusting Child–Pugh classification and Model…”
Get full text

Safety, tolerability, and efficacy of pegylated‐interferon alfa‐2a plus ribavirin in HCV‐related decompensated cirrhotics by TEKIN, F., GUNSAR, F., KARASU, Z., AKARCA, U., ERSOZ, G.

“…Summary Background  Pretransplantation clearance of hepatitis C virus (HCV)‐RNA reduces the risk of HCV recurrence after transplantation. Furthermore, a…”
Get full text

P928 TELBIVUDIN: MORE CAUTION IS NEEDED IN LIVER TRANSPLANT RECIPIENTS by Karasu, Z, Turan, I, Duman, S, Sözbilen, M, Gunsar, F, Ersoz, G, Akarca, U

Get full text

P1087 ENTECAVIR AND TENOFOVIR MONOTHERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER TURKISH STUDY IN CLINICAL PRACTICE by Idilman, R, Keskin, O, Gunsar, F, Koruk, M, Meral, C.E, Tuzun, A, Gulsen, M, Elhan, A.H, Akarca, U.S, Yurdaydin, C

Get full text

Late hepatic artery thrombosis after orthotopic liver transplantation by Gunsar, Fulya, Rolando, Nancy, Pastacaldi, Sabrina, Patch, David, Raimondo, Maria L., Davidson, Brian, Rolles, Keith, Burroughs, Andrew K.

“…Late hepatic artery thrombosis (HAT) is a rare complication after orthotopic liver transplantation (OLT), conventionally described as occurring more than 30…”
Get full text

492 IL28B GENOTYPE HAS NO IMPACT ON SPONTANEOUS HEPATITIS B SURFACE ANTIGEN (HBSAG) CLEARANCE IN INACTIVE CARRIERS: A LONG TERM, CASE-MATCHED RETROSPECTIVE COHORT STUDY by Yapali, S, Cetintas, A, Salman, E, Gunsar, F, Oruc, N, Vardar, R, Karasu, Z, Ersoz, G, Ozutemiz, O, Akarca, U.S

Get full text

Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach by CHAN, C.‐W., TSOCHATZIS, E. A., CARPENTER, J. R., RIGAMONTI, C., GUNSAR, F., BURROUGHS, A. K.

“…Aliment Pharmacol Ther 31, 573–582 Summary Background  Current survival models for primary biliary cirrhosis have limited precision for medium and long‐term…”
Get full text

Long‐term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow‐up to 12 years by Chan, C. W., Gunsar, F., Feudjo, M., Rigamonti, C., Vlachogiannakos, J., Carpenter, J. R., Burroughs, A. K.

“…Summary Background : It is uncertain whether ursodeoxycholic acid therapy slows down the progression of primary biliary cirrhosis, according to two…”
Get full text

342 A PROSPECTIVE EVALUATION OF HISTOLOGIC CHANGES IN NON-ALCOHOLIC FATTY LIVER DISEASE by Unal, N.G, Yilmaz, F, Gunsar, F, Nart, D, Vardar, R, Karasu, Z, Ersoz, G, Akarca, U.S

Get full text

737 HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE RATES AND ASSOCIATED FACTORS IN CHRONIC HEPATITIS B INFECTION by Yapali, S, Bayrakci, B, Akyildiz, M, Vardar, R, Gunsar, F, Ersoz, G, Karasu, Z, Ilter, T, Akarca, U.S

Get full text

162 EFFECTS OF ERYTHROPOIETIN IN THIOACETAMIDE INDUCED FULMINANT HEPATIC FAILURE IN RATS by Oruc, N, Ersoz, G, Yilmaz, F, Akarca, U.S, Gunsar, F, Karasu, Z, Ozutemiz, O

Get full text

Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity by Bogdanos, D.-P., Baum, H., Gunsar, F., Arioli, D., Polymeros, D., Ma, Y., Burroughs, A. K., Vergani, D.

“…Background: Primary biliary cirrhosis (PBC) is an immune-mediated chronic cholestatic disease characterized by the presence of antibodies directed…”
Get full text

997 FIBROSIS SHOULD BE INCLUDED INTO THE NON- ALCOHOLIC STEATOHEPATITIS SCORING SYSTEM FOR BEING MORE PROGNOSTICATIVE by Gunsar, F, Yilmaz, F, Unal, N.G, Bayrakci, B, Karasu, Z, Nart, D, Ersoz, G, Akarca, U.S

Get full text

A Pilot Study: Longer Duration of Posttransplant Hepatitis C Virus Therapy May Increase the Sustained Response Rate by Karasu, Z, Akay, S, Yilmaz, F, Akarca, U, Ersoz, G, Gunsar, F, Kilic, M

“…Abstract Background Although end of treatment virological responses are similar in posttransplant patients with recurrent chronic hepatitis C virus infection…”
Get full text

HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence by Karasu, Z., Ozacar, T., Akarca, U., Ersoz, G., Erensoy, S., Gunsar, F., Kobat, A., Tokat, Y., Batur, Y.

“…Anti‐HBs immunoglobulins (HBIG) and lamivudine are main options to prevent hepatitis B virus (HBV) reinfection after liver transplantation. Although they are…”
Get full text

Living Donor Liver Transplantation From Hepatitis B Core Antibody Positive Donors by Kobak, A. Celebi, Karasu, Z, Kilic, M, Ozacar, T, Tekin, F, Gunsar, F, Ersoz, G, Yuzer, Y, Tokat, Y

“…Abstract Liver allografts from donors previously exposed to hepatitis B virus (HBV) carry the risk of transmission of HBV infection to immunosuppressed…”
Get full text

Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation by Akyildiz, M, Karasu, Z, Arikan, C, Kilic, M, Zeytunlu, M, Gunsar, F, Ersoz, G, Akarca, U, Batur, Y, Tokat, Y

“…It is not clear whether pretransplantation MELD (model for End-Stage Liver Disease) score can foresee posttransplant outcome. We retrospectively evaluated 80…”
Get full text

399 DELTA VIRUS COINFECTION DOES NOT INCREASE, BUT HCV COINFECTION INCREASE THE HBSAG LOSS, IN CHRONIC HBV INFECTION by Yapali, S, Bayrakci, B, Gunsar, F, Ersoz, G, Karasu, Z, Akarca, U.S

Get full text